Mackay Shields LLC’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-58,162
Closed -$1.42M 1141
2021
Q1
$1.42M Sell
58,162
-32,992
-36% -$745K 0.01% 897
2020
Q4
$1.77M Buy
91,154
+52,100
+133% +$958K 0.01% 897
2020
Q3
$679K Sell
39,054
-54,700
-58% -$1.17M ﹤0.01% 1121
2020
Q2
$2.46M Sell
93,754
-3,900
-4% -$96.8K 0.02% 667
2020
Q1
$2.36M Sell
97,654
-39,800
-29% -$973K 0.02% 598
2019
Q4
$3.41M Buy
137,454
+3,300
+2% +$76.6K 0.02% 651
2019
Q3
$2.86M Buy
134,154
+15,200
+13% +$416K 0.02% 752
2019
Q2
$3.78M Buy
118,954
+69,392
+140% +$2.18M 0.03% 655
2019
Q1
$1.64M Buy
49,562
+4,600
+10% +$143K 0.01% 786
2018
Q4
$1.45M Sell
44,962
-52,159
-54% -$1.97M 0.01% 790
2018
Q3
$4.17M Sell
97,121
-3,100
-3% -$146K 0.03% 487
2018
Q2
$4.62M Sell
100,221
-11,500
-10% -$509K 0.03% 498
2018
Q1
$4.43M Buy
+111,721
New +$4.14M 0.03% 525

Other funds holding PAHC

Mackay Shields LLC's PAHC Position: Q2 2021 in Review

Mackay Shields LLC sold out of Phibro Animal Health (PAHC) in Q2 2021, closing a stake of 58,162 shares — an estimated $1.42M sold.

Mackay Shields LLC first reported a position in PAHC in Q1 2018 and held it in 13 quarters. The position peaked at $4.62M in Q2 2018. 146 funds tracked by Wall St. Rank hold PAHC as of Q2 2021.

  • Mackay Shields LLC reported no remaining Phibro Animal Health position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 58,162 Phibro Animal Health shares in Q2 2021, an estimated $1.42M.
  • Mackay Shields LLC first reported a position in Phibro Animal Health in Q1 2018 and held it in 13 quarters.
  • Mackay Shields LLC's Phibro Animal Health position peaked at $4.62M in Q2 2018.
  • 146 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.